Awaye Plus
Awaye Plus, licence 80097982: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Lumiera Health Innovations Inc.
- NPN or DIN-HM
- 80097982
- Status
- Active licence
- Licence date
- 30 March 2020
- Revision date
- 25 August 2021
- Form
- Crème
- Route of administration
- Topique
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (E)-8-Méthyl-N-vanillyl-6-nonenamide Source : Capsicum annuum - fruit | 0.075 % | Not calculated |
| Bêta-caryophyllène Source : Syzygium aromaticum - fleur | 20.0 % | Not calculated |
Non-medicinal ingredients
Alcool cétylique, Stéarate de glycéryle, Gomme de xanthane, Laureth-7, Acide oléique, Sorbate de potassium, Poly(acrylamide), Poly(sorbate) 80, Stéarate de PEG-100, Eau distillée, alcool benzylique, Isoparaffine en C13 à 14
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | Not specified | Not specified |
Uses authorised in Canada
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis. Used for the (temporary) relief of muscle and joint pain associated with rheumatoid arthritis or osteoarthritis, and pain of tendons and ligaments. Used to relieve skin (cutaneous) pain associated with conditions such as post-herpetic neuralgia and/or diabetic neuropathy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If symptoms persist and/or worsen after 1-2 weeks or re-occur within a few days, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80097982
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.